These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3169096)

  • 1. Combined intermittent dearterialization and intraperitoneal 5-fluorouracil administration for liver tumours in the rat.
    Mack P; Jeppsson B; Widlus D; Hägerstrand I; Bengmark S
    Eur J Cancer Clin Oncol; 1988 May; 24(5):909-13. PubMed ID: 3169096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated dearterializations of an experimental liver tumor: short- and long-term results.
    Wang LQ; Persson BG; Jeppsson B; Bengmark S
    J Surg Res; 1994 Jan; 56(1):53-9. PubMed ID: 8277769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose turnover in rats undergoing transient dearterialization for liver malignancy.
    Mack P; Ahrén B; Jeppsson B; Bengmark S
    J Surg Res; 1989 Nov; 47(5):447-52. PubMed ID: 2811358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion (HAI) chemotherapy proves to be advantageous in the treatment of experimental liver tumors.
    Schlag P; Dörsam J; Aguiar JL; Bartkowski R; Berger M
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1013-8. PubMed ID: 3409939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of portal deviation on the effect of repeat dearterializations of a transplantable adenocarcinoma to the rat liver.
    Wang LQ; Persson BG; Bengmark S
    HPB Surg; 1994; 8(1):37-41. PubMed ID: 7993863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral formation after repeated transient dearterialization of the rat liver.
    Wang LQ; Persson BG; Bengmark S
    HPB Surg; 1992; 6(2):105-12; discussion 113. PubMed ID: 1284031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of collaterals in intermittent and permanent ischemia of the liver.
    Ok E; Yilmaz Z; Akgün E; Sözüer EM; Yeşilkaya Y; Oztürk F
    HPB Surg; 1996; 10(1):35-40. PubMed ID: 9187550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of ischemic therapy for hepatic tumors.
    Bengmark S; Jeppsson B
    Surg Clin North Am; 1989 Apr; 69(2):411-8. PubMed ID: 2648621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retarding liver cancer growth in the rat by transient repeated hepatic dearterialization.
    Mack P; Jeppsson B; Rajszys P; Kobayashi H; Asakawa H; Bengmark S
    J Surg Res; 1989 Feb; 46(2):123-8. PubMed ID: 2918714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin response to glucose challenge after transient hepatic dearterialization for rat liver malignancy.
    Mack P; Ahrén B; Jeppsson B; Bengmark S
    J Surg Res; 1989 Aug; 47(2):124-8. PubMed ID: 2666752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreduction of RSU 1069 and mitomycin C after dearterialization.
    Wang LQ; Persson BG; Bengmark S
    Eur J Surg Oncol; 1993 Oct; 19(5):455-62. PubMed ID: 8405482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C and lipiodol do not improve the effect of intermittent hepatic artery occlusion on liver tumour growth. An experimental study in the rat.
    Sjövall S; Foss A; Audisio R; Ahrén B; Bengmark S
    Anticancer Res; 1991; 11(5):1823-5. PubMed ID: 1662927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient repeated dearterialization combined with intra-arterial infusion of oncolytic drugs in the treatment of liver tumors.
    Bengmark S; Nobin A; Jeppsson B; Tranberg KG
    Recent Results Cancer Res; 1983; 86():68-74. PubMed ID: 6648014
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of 2-deoxy-D-glucose and arterial ischaemia on glucose oxidation and growth of liver cancer in the rat.
    Mack P; Ahrén B; Jeppsson B; Kan Z; Bengmark S
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1433-7. PubMed ID: 3181267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors.
    Dahl EP; Frelund PE; Tylén U; Bengmark S
    Ann Surg; 1981 Jan; 193(1):82-8. PubMed ID: 7458454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
    Jakobsson B; Roos G; el Hag IA; Jönsson PE; Stenram U
    Res Exp Med (Berl); 1992; 192(1):13-21. PubMed ID: 1570410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
    Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein.
    Wang LQ; Persson BG; Bergqvist L; Bengmark S
    Cancer; 1994 Nov; 74(9):2454-9. PubMed ID: 7923000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the rat.
    van der Wilt CL; Marinelli A; Pinedo HM; Cloos J; Smid K; van de Velde CJ; Peters GJ
    Eur J Cancer; 1995; 31A(5):754-60. PubMed ID: 7640050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial, portal or combined arterio-portal regional chemotherapy in experimental liver tumours?
    Riemenschneider T; Ruf C; Kratzsch HC; Ziegler M; Späth G
    J Cancer Res Clin Oncol; 1992; 118(8):597-600. PubMed ID: 1387647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.